
Adamas Pharmaceuticals, Inc. ADMS
Adamas Pharmaceuticals, Inc. Finanzkreislauf | ADMS
Finanzkreislauf Jährlich Adamas Pharmaceuticals, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 59.1 | 14.9 | -21 | -5.27 | -30.7 | -45.5 | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 59.1 | -45.5 | -4.73 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals
CPRX
|
120 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
127 | $ 26.14 | 3.24 % | $ 1.26 B | ||
|
Catalyst Biosciences
CBIO
|
285 | $ 14.79 | 6.25 % | $ 1.32 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
ADiTx Therapeutics
ADTX
|
-1.09 M | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Apellis Pharmaceuticals
APLS
|
115 | - | - | $ 5.18 B | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
64.1 | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
7.32 | $ 0.36 | -10.07 % | $ 26.4 K | ||
|
Cara Therapeutics
CARA
|
81.1 | - | -3.03 % | $ 260 M | ||
|
ChromaDex Corporation
CDXC
|
65.3 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
966 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-1.6 K | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-1.6 K | - | -4.36 % | $ 27 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
-1.76 K | - | 11.68 % | $ 8.97 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
-850 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
-1.37 K | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
-608 | - | - | $ 889 M | ||
|
Amicus Therapeutics
FOLD
|
828 | - | - | $ 4.47 B | ||
|
GlycoMimetics
GLYC
|
303 | - | 9357.83 % | $ 1.01 B | ||
|
Happiness Biotech Group Limited
HAPP
|
-30.4 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
-79.7 | $ 9.97 | -2.25 % | $ 1.62 B | ||
|
KalVista Pharmaceuticals
KALV
|
-816 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
-73.8 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
38.3 | - | - | $ 53.3 M | ||
|
NovaBay Pharmaceuticals
NBY
|
28 | - | - | $ 11.3 M |